Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer
暂无分享,去创建一个
A. Harris | A. Harris | C. Potter | Cps Potter | Al Harris | C. Potter | Cps Potter | AL Harris | Cps Potter | AL Harris | Cps Potter | AL Harris
[1] Robert J. Gillies,et al. Acidic pH enhances the invasive behavior of human melanoma cells , 1996, Clinical & Experimental Metastasis.
[2] V. Lehto,et al. Immunohistochemical demonstration of the carbonic anhydrase isoenzymes I and II in pancreatic tumours , 1995, The Histochemical Journal.
[3] S. Chu,et al. The aberrant expression of cytosolic carbonic anhydrase and its clinical significance in human non-small cell lung cancer. , 2002, Cancer letters.
[4] Jan Svoboda,et al. Gastric hyperplasia in mice with targeted disruption of the carbonic anhydrase gene Car9. , 2002, Gastroenterology.
[5] W. Sly,et al. The expression of carbonic anhydrase II in hematological malignancies. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[6] A. Harris,et al. The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer , 2002, British Journal of Cancer.
[7] Kerry S. Smith,et al. Carbonic Anhydrase: New Insights for an Ancient Enzyme* 210 , 2001, The Journal of Biological Chemistry.
[8] M. Lerman,et al. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. , 2001, Cancer research.
[9] A. Harris,et al. Towards a biological staging model for operable non-small cell lung cancer. , 2001, Lung cancer.
[10] D. Silverman,et al. The catalytic properties of human carbonic anhydrase IX. , 2001, Biochemical and biophysical research communications.
[11] J. Pastorek,et al. Transmembrane carbonic anhydrase, MN/CA IX, is a potential biomarker for biliary tumours. , 2001, Journal of hepatology.
[12] A. Harris,et al. Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] J. Pastorek,et al. Characterization of the MN/CA 9 promoter proximal region: a role for specificity protein (SP) and activator protein 1 (AP1) factors. , 2001, The Biochemical journal.
[14] A. Harris,et al. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. , 2001, Cancer research.
[15] R. Figlin,et al. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor. , 2001, Cancer research.
[16] A. Harris,et al. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. , 2001, Cancer research.
[17] A. Harris,et al. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] G N Shah,et al. Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[19] S. Saga,et al. Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma , 2001, British Journal of Cancer.
[20] A. Harris,et al. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. , 2001, Cancer research.
[21] V. Sukhatme,et al. VHL tumor suppressor regulates Cl-/HCO3- exchange and Na+/H+ exchange activities in renal carcinoma cells. , 2001, Physiological genomics.
[22] W. Sly,et al. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. , 2001, The American journal of pathology.
[23] W. Sly,et al. Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. , 2001, The American journal of pathology.
[24] C. Supuran,et al. Carbonic anhydrase inhibitors: sulfonamides as antitumor agents? , 2001, Bioorganic & medicinal chemistry.
[25] F. Howe,et al. Why are cancers acidic? A carrier-mediated diffusion model for H+ transport in the interstitial fluid. , 2001, Novartis Foundation symposium.
[26] R. Gillies,et al. pH and chemotherapy. , 2001, Novartis Foundation symposium.
[27] P H Watson,et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. , 2000, Cancer research.
[28] W. Sly,et al. Expression of the Membrane-associated Carbonic Anhydrase Isozyme XII in the Human Kidney and Renal Tumors , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[29] W. Sly,et al. Expression of transmembrane carbonic anhydrase isoenzymes IX and XII in normal human pancreas and pancreatic tumours , 2000, Histochemistry and Cell Biology.
[30] Katz,et al. Biomarkers of renal cell carcinoma. Past and future considerations. , 2000, Urologic oncology.
[31] H. Ueno,et al. Expression of carbonic anhydrase I or II and correlation to clinical aspects of colorectal cancer. , 2000, Hepato-gastroenterology.
[32] E. Swenson,et al. The distribution and physiological significance of carbonic anhydrase in vertebrate gas exchange organs. , 2000, Respiration physiology.
[33] J. Pastorek,et al. Human tumour-associated cell adhesion protein MN/CA IX: identification of M75 epitope and of the region mediating cell adhesion , 2000, British Journal of Cancer.
[34] E. Stanbridge,et al. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia , 2000, Cancer.
[35] W. Sly,et al. Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[36] W. Sly,et al. Expression of a novel transmembrane carbonic anhydrase isozyme XII in normal human gut and colorectal tumors. , 2000, The American journal of pathology.
[37] G. Gros,et al. Carbon dioxide transport and carbonic anhydrase in blood and muscle. , 2000, Physiological reviews.
[38] W. Sly,et al. The membrane carbonic anhydrases: from CO2 transport to tumor markers. , 2000, EXS.
[39] I. M. Spencer,et al. The roles of carbonic anhydrase in metabolism, cell growth and cancer in animals. , 2000, EXS.
[40] A. Burny,et al. Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma. , 1999, The European respiratory journal.
[41] J. Pastorek,et al. Study of in vitro conditions modulating expression of MN/CA IX protein in human cell lines derived from cervical carcinoma. , 1999, Neoplasma.
[42] S. Larson,et al. Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[43] M. Wei,et al. Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[44] J. Pastorek,et al. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. , 1998, The American journal of pathology.
[45] G N Shah,et al. Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[46] D. Fisher,et al. Regulation of Proliferation-Survival Decisions during Tumor Cell Hypoxia , 1998, Molecular and Cellular Biology.
[47] N. Delamere,et al. Cytoplasmic pH Responses to Carbonic Anhydrase Inhibitors in Cultured Rabbit Nonpigmented Ciliary Epithelium , 1998, The Journal of Membrane Biology.
[48] P. Vaupel,et al. The influence of tumor blood flow and microenvironmental factors on the efficacy of radiation, drugs and localized hyperthermia , 1997, Klinische Padiatrie.
[49] R. Odze,et al. MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker. , 1997, Human pathology.
[50] Adrian L. Harris,et al. Targeting gene expression to hypoxic tumor cells , 1997, Nature Medicine.
[51] J. Pastorek,et al. Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts. , 1997, Gastroenterology.
[52] R. Kettmann,et al. Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. , 1996, Genomics.
[53] J. Schlessinger,et al. The carbonic anhydrase domain of receptor tyrosine phosphatase β is a functional ligand for the axonal cell recognition molecule contactin , 1995, Cell.
[54] R. Kettmann,et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. , 1994, Oncogene.
[55] J. Pastorek,et al. Expression of MaTu‐MN protein in human tumor cultures and in clinical specimens , 1993, International journal of cancer.
[56] B. Teicher,et al. A carbonic anhydrase inhibitor as a potential modulator of cancer therapies. , 1993, Anticancer Research.
[57] S. Frankel,et al. Carbonic anhydrase: a marker for the erythroid phenotype in acute nonlymphocytic leukemia. , 1986, Blood.